通威股份(600438.SH)漲超4%創4個月新高,業績+擴產提振
格隆匯7月1日丨通威股份盤中一度漲超4%報45.19元,股價創4個月新高,市值超2000億元。公司昨晚公佈業績預吿,預計2021年半年度實現歸屬於上市公司股東的淨利潤與上年同期相比將增加17.9-19.9億元,同比增長177%-197%。另外,公司規劃在樂山市五通橋區新增投資建設年產20萬噸高純晶硅項目,總投資預計140億元,項目按每期10萬噸分兩期實施,一期計劃2022年12月底前投產。機構普遍認為通威股份業績如期爆發,且硅料擴產提速超預期。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.